Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.

Quách TD, Manjarrez-Orduño N, Adlowitz DG, Silver L, Yang H, Wei C, Milner EC, Sanz I.

J Immunol. 2011 Apr 15;186(8):4640-8. doi: 10.4049/jimmunol.1001946.

2.

Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors.

Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC.

J Exp Med. 2009 Jan 16;206(1):139-51. doi: 10.1084/jem.20080611.

3.

Endogenous antigen tunes the responsiveness of naive B cells but not T cells.

Zikherman J, Parameswaran R, Weiss A.

Nature. 2012 Sep 6;489(7414):160-4. doi: 10.1038/nature11311.

4.

Functionally responsive self-reactive B cells of low affinity express reduced levels of surface IgM.

Kirchenbaum GA, St Clair JB, Detanico T, Aviszus K, Wysocki LJ.

Eur J Immunol. 2014 Apr;44(4):970-82. doi: 10.1002/eji.201344276.

5.

Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes.

Liubchenko GA, Appleberry HC, Striebich CC, Franklin KE, Derber LA, Holers VM, Lyubchenko T.

J Autoimmun. 2013 Feb;40:111-21. doi: 10.1016/j.jaut.2012.09.001.

6.

Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.

Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, Samuels J, Berman J, Buckner JH, Cunningham-Rundles C, Meffre E.

Blood. 2010 Jun 17;115(24):5026-36. doi: 10.1182/blood-2009-09-243071.

7.
8.

CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.

Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF.

J Exp Med. 1997 Dec 1;186(11):1923-31.

10.

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.

Brink R, Goodnow CC, Crosbie J, Adams E, Eris J, Mason DY, Hartley SB, Basten A.

J Exp Med. 1992 Oct 1;176(4):991-1005.

12.

Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin.

Pezzutto A, Rabinovitch PS, Dörken B, Moldenhauer G, Clark EA.

J Immunol. 1988 Mar 15;140(6):1791-5.

PMID:
3257985
13.

CD22 associates with the human surface IgM-B-cell antigen receptor complex.

Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA.

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3236-40.

14.

Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.

Rossi EA, Goldenberg DM, Michel R, Rossi DL, Wallace DJ, Chang CH.

Blood. 2013 Oct 24;122(17):3020-9. doi: 10.1182/blood-2012-12-473744.

15.

Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.

Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM.

J Immunol. 1998 Feb 15;160(4):1565-72.

16.

Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.

Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK.

J Immunol. 2003 Nov 15;171(10):5244-54.

17.

Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.

Isaák A, Gergely P Jr, Szekeres Z, Prechl J, Poór G, Erdei A, Gergely J.

Int Immunol. 2008 Feb;20(2):185-92. doi: 10.1093/intimm/dxm132.

PMID:
18182380
18.

Autoreactivity and the positive selection of B cells.

Übelhart R, Jumaa H.

Eur J Immunol. 2015 Nov;45(11):2971-7. doi: 10.1002/eji.201444622. Review.

19.

A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells.

Soulas P, Koenig-Marrony S, Julien S, Knapp AM, Garaud JC, Pasquali JL, Martin T.

Eur J Immunol. 2002 Sep;32(9):2623-34.

20.

Reversible expression of CD138 on mature follicular B cells is downregulated by IL-4.

Lee JG, Moon H, Park C, Shin SH, Kang K, Kim TJ.

Immunol Lett. 2013 Nov-Dec;156(1-2):38-45. doi: 10.1016/j.imlet.2013.09.004.

PMID:
24029663

Supplemental Content

Support Center